The Lung Cancer Research Foundation (LCRF), in collaboration with 23andMe Holding Co. and 20 lung cancer advocacy organizations, has officially announced a study, which...
The Lung Cancer Research Foundation (LCRF), in collaboration with 23andMe Holding Co. and 20 lung cancer advocacy organizations, has officially announced a study, which...
Invitae, a leading medical genetics company, has officially announced the launch of its Unlock™ Behind the Seizure® program, which is designed to provide you...
Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, has officially secured FDA's Fast Track Designation for its 99mTc-maraciclatide as...
